Company Profile
Brainstorm Cell Therapeutics Inc. Stock Price, News & Analysis
- Ticker:
- BCLI
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Brainstorm Cell Therapeutics sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly.
Stock performance
0.91 USD (+1.11%)
Close
Last updated: June 23, 2026 at 00:00
—
Market cap
Why the stock is moving
BCLI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Brainstorm Cell Therapeutics sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly.
Business Model Characteristics
Brainstorm Cell Therapeutics follows a platform-led model where readouts, manufacturing progress, and commercialization milestones matter as much as the initial science. The market tends to reprice the stock quickly whenever adoption, safety, or label-expansion signals improve.
Position Within the Biotechnology Landscape
Compared with larger diversified biotech peers, Brainstorm Cell Therapeutics sits at the high-catalyst end of the landscape, where cell therapy names can move sharply on data, approvals, and launch milestones.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
Source: Brainstorm Cell Therapeutics Inc.
- 02
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
Source: Brainstorm Cell Therapeutics Inc.
- 03
BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
Source: Brainstorm Cell Therapeutics Inc.
- 04
BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
Source: Brainstorm Cell Therapeutics Inc.
- 05
BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
Source: Brainstorm Cell Therapeutics Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Brainstorm Cell Therapeutics Inc. (BCLI)?
Brainstorm Cell Therapeutics Inc. (BCLI) most recently closed at 0.91 USD, a +1.11% move versus the previous session.
What does Brainstorm Cell Therapeutics Inc. do?
Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases. Investors usually watch how the platform converts data, manufacturing readiness, and launch execution into a durable oncology or specialty franchise.
On which exchange is BCLI stock listed?
Brainstorm Cell Therapeutics Inc. (BCLI) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Brainstorm Cell Therapeutics sits inside the cell therapy universe where trial execution and regulatory timing can change the investment case quickly., Biotechnology.
What is Brainstorm?
Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases.
Which conditions is Brainstorm Cell Therapeutics Inc. targeting with Brainstorm?
Brainstorm Cell Therapeutics Inc. is associated with oncology based on its company overview and current catalyst commentary.
What is Cell?
Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases.
What is Therapeutics?
Brainstorm Cell Therapeutics is a cell therapy company focused on translating complex living-cell science into clinically meaningful treatments for hard-to-treat diseases.